Expression of mucin antigens and Lewis X-related antigens in carcinomas and dysplasia of the pharynx and larynx

Pathology International

Volumn 46, Issue 9, 1996, Pages 646-655

  Itoh, Tetsuhiko ^a   Yonezawa, Suguru ^a   Nomoto, Mitsuharu ^a   Ueno, Kazuyoshi ^a   Kim, Young S ^b   Sato, Eiichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

immunohistochemistry; Lewis X related antigen; mucin antigen; pharyngolaryngeal carcinoma

Indexed keywords

BLOOD GROUP ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CELL DIFFERENTIATION; CONTROLLED STUDY; EPITHELIUM DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; PHARYNX CARCINOMA; PRIORITY JOURNAL;

EID: 0029742026     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1996.tb03667.x     Document Type: Article

References (47)

1. Itzkowitz SH, Yuan M, Montgomery CK et al. Expression of Tn, sialyl-Tn, and T antigens in human colon cancer. Cancer Res. 1989; 49: 197-204.
2. Springer GF. T and Tn, general carcinoma autoantigens. Science 1984; 224: 1198-1206.
3. Yonezawa S, Tachikawa T, Shin S, Sato E. Sialosyl-Tn antigen: Its distribution in normal human tissue and expression in adenocarcinomas. Am. J. Clin. Pathol. 1992; 98: 167-174.
4. Takahashi HK, Metoki R, Hakomori S. Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor-associated α-N-acetylgalactosaminyl epitope) that does not cross-react with blood group A antigen. Cancer Res. 1988; 48: 4361-4367.
5. Kjeldsen T, Clausen H, Hirohashi S, Ogawa T, Iijima H, Hakomori S. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialyl-2-6 α-N-acetylgalactosaminyl (sialyl-Tn) epitope. Cancer Res. 1988; 48: 2214-2220.
6. Huang J, Byrd JC, Siddiqui B, Yuan M, Lau E, Kim YS. Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen. Dis. Markers 1992; 10: 81-94.
7. Lotan R, Skutelsky E, Danon D, Sharon N. The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea). J. Biol. Chem. 1975; 250: 8518-8523.
8. Springer GF, Desai PR, Murphy MS, Yang HJ, Scalon EF. Precursors of the blood group MN antigens as human carcinoma associated antigens. Transfusion 1979; 19: 233-249.
9. Cooper HS. Peanut lectin-binding sites in large bowel carcinoma. Lab. Invest. 1982; 47: 383-390.
10. Howard DR, Batsakis JG. Cytostructural localization of a tumor-associated antigen. Science 1980; 210: 201-203.
11. Howard DR, Ferguson P, Batsakis JG. Carcinoma-associated cytostructural antigenic alterations: Detection by lectin binding. Cancer 1981; 47: 2872-2877.
12. Kim YS, Byrd JC. Colonic and pancreatic mucin glycoproteins expressed in neoplasia. In: Pretlow TG II, Pretlow TP, eds. Biochemical and Molecular Aspect of Selected Cancers, vol. 1. Academic, San Diego, 1991; 277-311.
13. Yonezawa S, Byrd JC, Dahiya R et al. Differential mucin gene expression in human pancreatic and colon cancer cells. Biochem. J. 1991; 276: 599-605.
14. Gum JG. Mucin genes and the proteins they encode: Structure, diversity, and regulation. Am. J. Respir. Cell Mol. Biol. 1992; 7: 557-564.
15. Itzkowitz SH, Yuan M, Fukushi Y et al. Lewis X- and sialylated Lewis X- related antigen expression in human malignant and non-malignant colonic tissues. Cancer Res. 1986; 46: 2627-2632.
16. y blood group-related antigens in human malignant, premalignant and non-malignant colonic tissues. Cancer Res. 1986, 46: 5985-5992.
17. Matsushita Y, Cleary K, Ota DM et al. Sialyl-dimeric Lewis X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases. Lab. Invest. 1990; 63: 780-791.
18. 6) in normal and tumor tissue defined by its monoclonal antibody FH6. Cancer Res. 1985; 45: 3711-3717.
19. Zenita K, Kirihara Y, Kitahara A et al. Fucosylated type-2 chain polylactosamine antigen in human lung cancer. Int. J. Cancer 1988; 41: 344-349.
20. Shimizu T, Yonezawa S, Tanaka S, Sato E. Expression of Lewis X-related antigens in adenocarcinomas of lung. Histopathology 1993; 22: 549-555.
21. Kufe D, Inghirami G, Abe M, Hayes D, Wheeler HJ, Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984; 3: 223-232.
22. Broders AC. The microscopic grading of cancer. Surg. Clin. North Am. 1941; 21: 947.
23. Tabata M, Yonezawa S, Sugihara K, Yamashita S, Maruyama I. The use of thrombomodulin to study epithelial cell differentiation in neoplastic and non-neoplastic oral lesions. J. Oral Pathol. Med. 1995; 24: 443-449.
24. World Health Organization. Definition of leukoplakia and related lesions: An aid to studies on oral precancer. Oral Surg. Oral Med. Oral Pathol. 1978; 46: 518-539.
25. Hermanek P, Sobin LH, eds. TNM classification of malignant tumors, UICC International Union Against Cancer, 4th, fully revised edn. 1987.
26. Siddiqui J, Abe M, Hayes D et al. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc. Natl Acad. Sci. USA 1988; 85: 2320-2323.
27. Abe M, Kufe D. Characterization of cis-acting elements regulating transcription of the human DF3 breast carcinoma-associated antigen (MUC1) gene. Proc. Natl Acad. Sci. USA 1993; 90: 282-286.
28. Sekine H, Hayakawa Y, Mori Y et al. Characterization of the two monoclonal antibodies against breast cancer. Jikeikai Med. J. 1988; 35: 209-224.
29. Sekine H, Ohno T, Kufe DW. Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas. J. Immunol. 1985; 135: 3610-3615.
30. Gum JR, Byrd JC, Hicks JW, Toribara NW, Lamport DTA, Kim YS. Molecular cloning of human intestinal mucin cDNAs. J. Biol. Chem. 1989; 264: 6480-6487.
31. Huang J, Byrd JC, Siddiki B et al. Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen. Dis. Markers 1992; 10: 81-94.
32. Hsu SM, Gaine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981; 29: 577-580.
33. Osako M, Yonezawa S, Siddiki B et al. Immunohistochemical study of mucin carbohydrates and core protein in human pancreatic tumors. Cancer 1993; 71: 2191-2199.
34. Yamashita K, Yonezawa S, Tanaka S et al. Immunohistochemical study of mucin carbohydrates and core protein in hepatolithiasis and cholangiocarcinoma. Int. J. Cancer 1993; 55: 82-91.
35. Tashiro Y, Yonezawa S, Kim YS, Sato E. Immunohistochemical study of mucin carbohydrades and core proteins in human ovarian tumors. Hum. Pathol. 1994; 25: 364-372.
36. Ikeda Y, Kuwano H, Ikebe M et al. Immunohistochemical detection of CEA, CA19-9, and DF3 in esophageal carcinoma limited to the submucosal layer. J. Surg. Oncol. 1994; 56: 7-12.
37. Gum JR. Mucin genes and the proteins they encode: Structure, diversity, and regulation. Am. J. Respir. Cell Mol. Biol. 1992; 7: 557-564.
38. Carraway KL, Fregien N. Mucin structure and function: Insights from molecular biology. Trends Glycosci. Glycotech. 1995; 33: 31-44.
39. Nakashima T, Yano G, Hayashi I, Katsuta Y. Epithelial membrane antigen and S-100 protein-labeled cells in primary and metastatic laryngeal carcinomas. Head Neck 1992; 14: 445-451.
40. Dilulia NA, Yamakami K, Washington S, Bhavanandan VP. Effect of long-term culture of a human laryngeal carcinoma cell line on epitectin production and tumorigenicity in athymic mice. Glycosyl. Dis. 1994; 1: 21-30.
41. Toribara NW, Gum JR, Culhane PJ et al. MUC2 human small intestinal mucin gene structure: Repeated arrays and polymorphism. J. Clin. Invest. 1991; 88: 1005-1013.
42. Gum JR, Hicks JW, Toribara NW, Siddiki B, Kim YS. Molecular cloning of human intestinal mucin (MUC2) cDNA: Identification of the amino terminus and overall sequence similarity to Pre-Pro-von Willebrand factor. J. Biol. Chem. 1994; 269: 2440-2446.
43. Ikeda Y, Kuwano H, Baba K et al. Expression of sialyl-Tn antigens in normal squamous epithelium, dysplasia, and squamous cell carcinoma in the esophagus. Cancer Res. 1993; 53: 1706-1708.
44. Schuessler MH, Pintado S, Welt S et al. Blood group and blood group-related antigens in normal pancreas and pancreas cancer: Enhanced expression of precursor type 1, Tn, and sialyl-Tn in pancreas cancer. Int. J. Cancer 1991; 47: 180-187.
45. Itzkowitz SH, Kjeldsen T, Friera A et al. Expression of Tn, sialosyl Tn, and T antigen in human pancreas. Gastroenterology 1991; 100: 1691-1700.
46. Boland CR, Montgomery CK, Kim YS. Alterations in human colonic mucin occupation with cellular differentiation and malignant transformation. Proc. Natl Acad. Sci. USA 1982; 79: 2051-2055.
47. Tauchi K, Kakudo K, Machimura T, Makuuchi H, Mitomi T. Immunohistochemical studies of blood group-related antigens in human superficial esophageal carcinomas. Cancer 1991; 67: 3042-3050.